D-Cycloserine for anxiety disorders
Record ID 32010000853
English
Authors' objectives:
D-cycloserine, an established treatment modality for tuberculosis, is an N-methyl-D-aspartic acid (NMDA) receptor agonist currently being investigated for the treatment of anxiety disorders. The goal of treatment with D-cycloserine is to reduce the frequency and intensity of symptoms associated with anxiety disorders, and to improve patient functioning and quality of life.
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=9848
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Anxiety
- Behavior Therapy
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2009 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.